GervanoRA Announced the Release of Opportunity Assessments Report Titled “Cannabinoids (Cannabidiol – CBD & Tetrahydrocannabinol - THC) Based Drugs – Opportunity Assessments and Pipeline Analysis H2 2018”

GervanoRA Data Services (GDS) is a premier provider of market research analysis and services based in Goa, India has announced the release of their latest report titled Cannabinoids (Cannabidiol – CBD & Tetrahydrocannabinol - THC) Based Drugs – Opportunity Assessments and Pipeline Analysis H2 2018. This report provides competitive intelligence on cannabinoids based drugs pipeline analytics and opportunity assessments.

GervanoRA analyzed and assessed cannabinoids pipeline molecules and opportunities in the competitive space by covering more than 110 pipeline molecules in different stages of development and more than 35 companies which are actively involved in cannabinoids industry. To provide systematic pipeline analytics, we have segregated total pipeline molecules in to different segments like Pipeline Molecules by Geography, Pipeline Molecules by Drug Class, Pipeline Molecules by Mechanism of Action, Pipeline Molecules by Stage of development, and Pipeline molecules by Indication.

Report even covered analytics on pipeline molecules by type (Cannabidiol - CBD Vs Tetrahydrocannabinol -THC) and pipeline molecules by source of origin (Plant derived Vs Synthetic) without ignoring applications of cannabinoids and its expected market value in 11MM (Major Markets) with unmet needs and opportunities.

Report Highlights in Numerical
Total Pipeline Molecules 110
Number of Pipeline Molecules in Pre-Registration Phase 01
Number of Pipeline Molecules in Phase 3 Stage of Development 07
Number of Pipeline Molecules in Phase 2 Stage of Development 19
Number of Pipeline Molecules in Phase 1 Stage of Development 14
Number of Pipeline Molecules in Early R&D and Preclinical Stage of Development 70
Total Cannabidiol (CBD) Pipeline Molecules 65
Total Tetrahydrocannabinol (THC) Pipeline Molecules 16
Total Combination of CBD and THC Pipeline Molecules 16
Total Cannabigerol (CBG) Pipeline Molecules 01
Total Companies covered in detail 35
Number of Key Companies covered with SWOT Analysis 9
Number of Emerging companies covered with Drug profiles and competitive opportunities 22
Expected Total Cannabinoids Market by 2025 $48.5bn
Expected Total Cannabinoids based Pharma Industry Market by 2025 $29.59bn
Expected Total Cannabinoids based Food Industry Market by 2025 $7.27bn
Expected Total Cannabinoids based Cosmetic Industry Market by 2025 $16.64bn
Number of Pipeline Molecules Expected to Get Approval by 2023 06
Number of Pipeline Molecules Expected to Get Approval by 2019 01

Even In detailed Analytics provided on below aspects.
• Drivers and Restrains
• Covered all pipeline molecules and provided analytics by Stage of development, Geography, Drug Class, Mechanism of Action, Route of Administration, and Estimated Approval timelines. All the above sub segments are supported with unmet needs and opportunities
• Covered Market Dynamics by providing analytics on Deals (Acquisitions, Mergers, Partnering, Collaborations, Agreements and Terminations)
• Provided Patent Analysis of Pipeline Molecules
• Provided Analytics on Estimated Approval timelines of Pipeline Molecules
• Analytics on Geography wise Estimated timelines of Pipeline Molecules
• Covered All Emerging Companies with provided Competitive Opportunities
• Covered All Key Companies with provided Competitive Opportunities and SWOT Analysis

To view free sample report, Please follow the link: https://www.gervanora.com/request-for-sample-report/

Note: This report is available on promotional basis

Why Choose GervanoRA??
GervanoRA working dedicatedly for healthcare (Pharma & Medical Device) domain to empower our client’s business by assisting them in decision making with our wealthyness of database, expertise in analytics, and domain experts.
Vast & Tailor-made Database: GervanoRA utilizes its in-built rich database of pharmaceutical sector and Medical device sector to help our clients with their bespoke requirements. We have databases of Pharma Pipeline Drugs, Pharma News, Pharma Deal and Pipeline Medical Devices, Medical Device News and Medical Device Deal.
Coverage: We cover almost all major countries on the globe with providing Pharma & Medical device pipeline insights along with epidemiology, epidemiology forecast, Patent analysis, Insights on clinical trials and emerging opportunities. Using our database analytics, we are cracking the future numbers to assess market opportunities in healthcare domain.
Resources to meet the Goals: We have great number of experts, Analysts, Senior Researchers and Researchers to take care of our dynamic day to day process, like building database, updating the database, optimizing primary inputs, using internal tools analytics, Conducting KOL Interviews and Gathering field intelligence through paid surveys in all healthcare markets.

GervanoRA Data Services LLP is a premier provider of syndicated research reports, custom research reports and consulting services, based in Goa, India. GDS aims to deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial views of the competitive framework, and future market trends.

At GervanoRA Data Services, we're playing our part to help clients stay ahead of the curve. We collaboratively work with a wide range of organizations (KOLs) to garner valuable key insights.

To assist our global clients to attain their segment, sub segment specific goals, we are more enlightening them on domine specific live updates through our GervanoRA 360 Degree PharmMedTech Monthly Bulletin (Monthly Report) which serve our clients with bespoke requirements without missing any live update for the particular month, as we know how valuable it is to be stayed updated with day to day dynamic industry sectors.

GervanoRA Data Services LLP
Goa IT Inovation Center,
Goa Chamber of Commerce and Industry Bldg, 2nd Floor, S-2 Block,
Opp: Hyundai Showroom, Verna, South Goa,
Goa INDIA 403722
Email: sales@gervanora.com

This release was published on openPR.